Mark Erlander - Jun 10, 2021 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Erlander
Stock symbol
CRDF
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 04:11 PM
Next filing
Mar 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +435K +114.43% $0.00 815K Jun 10, 2021 Common Stock 435K $7.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 108,768 vest on 6/10/2022. 9,064 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.